Literature DB >> 35508655

Selective inhibition of miRNA processing by a herpesvirus-encoded miRNA.

Thomas Hennig1, Archana B Prusty2, Benedikt B Kaufer3, Adam W Whisnant1, Manivel Lodha1, Antje Enders1, Julius Thomas1, Francesca Kasimir1, Arnhild Grothey1, Teresa Klein4, Stefanie Herb1, Christopher Jürges1, Markus Sauer4,5, Utz Fischer2,6, Thomas Rudel6,7, Gunter Meister8, Florian Erhard1, Lars Dölken9,10, Bhupesh K Prusty11,12.   

Abstract

Herpesviruses have mastered host cell modulation and immune evasion to augment productive infection, life-long latency and reactivation1,2. A long appreciated, yet undefined relationship exists between the lytic-latent switch and viral non-coding RNAs3,4. Here we identify viral microRNA (miRNA)-mediated inhibition of host miRNA processing as a cellular mechanism that human herpesvirus 6A (HHV-6A) exploits to disrupt mitochondrial architecture, evade intrinsic host defences and drive the switch from latent to lytic virus infection. We demonstrate that virus-encoded miR-aU14 selectively inhibits the processing of multiple miR-30 family members by direct interaction with the respective primary (pri)-miRNA hairpin loops. Subsequent loss of miR-30 and activation of the miR-30-p53-DRP1 axis triggers a profound disruption of mitochondrial architecture. This impairs induction of type I interferons and is necessary for both productive infection and virus reactivation. Ectopic expression of miR-aU14 triggered virus reactivation from latency, identifying viral miR-aU14 as a readily druggable master regulator of the herpesvirus lytic-latent switch. Our results show that miRNA-mediated inhibition of miRNA processing represents a generalized cellular mechanism that can be exploited to selectively target individual members of miRNA families. We anticipate that targeting miR-aU14 will provide new therapeutic options for preventing herpesvirus reactivations in HHV-6-associated disorders.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35508655     DOI: 10.1038/s41586-022-04667-4

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  59 in total

1.  Identification of virus-encoded microRNAs.

Authors:  Sébastien Pfeffer; Mihaela Zavolan; Friedrich A Grässer; Minchen Chien; James J Russo; Jingyue Ju; Bino John; Anton J Enright; Debora Marks; Chris Sander; Thomas Tuschl
Journal:  Science       Date:  2004-04-30       Impact factor: 47.728

2.  Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.

Authors:  Xuezhong Cai; Shihua Lu; Zhihong Zhang; Carlos M Gonzalez; Blossom Damania; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

Review 3.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

Review 4.  Recognition of herpesviruses by the innate immune system.

Authors:  Søren R Paludan; Andrew G Bowie; Kristy A Horan; Katherine A Fitzgerald
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

Review 5.  Immune evasion strategies of the herpesviruses.

Authors:  I A York
Journal:  Chem Biol       Date:  1996-05

Review 6.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 7.  Metazoan MicroRNAs.

Authors:  David P Bartel
Journal:  Cell       Date:  2018-03-22       Impact factor: 41.582

Review 8.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 9.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

Review 10.  Metabolic regulation of mitochondrial dynamics.

Authors:  Prashant Mishra; David C Chan
Journal:  J Cell Biol       Date:  2016-02-08       Impact factor: 10.539

View more
  3 in total

Review 1.  [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].

Authors:  Herbert Renz-Polster; Carmen Scheibenbogen
Journal:  Inn Med (Heidelb)       Date:  2022-07-13

Review 2.  Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection.

Authors:  Cristian Arriaga-Canon; Laura Contreras-Espinosa; Rosa Rebollar-Vega; Rogelio Montiel-Manríquez; Alberto Cedro-Tanda; José Antonio García-Gordillo; Rosa María Álvarez-Gómez; Francisco Jiménez-Trejo; Clementina Castro-Hernández; Luis A Herrera
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

3.  miRNAs from Plasma Extracellular Vesicles Are Signatory Noninvasive Prognostic Biomarkers against Atherosclerosis in LDLr-/-Mice.

Authors:  Ke-Feng Zhai; Hong Duan; Yan Shi; Ya-Ru Zhou; Yuan Chen; Yao-Shuai Zhang; Zi-Peng Gong; Wen-Gen Cao; Jia Wu; Jun-Jun Wang
Journal:  Oxid Med Cell Longev       Date:  2022-08-17       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.